Study on social factors in transplant care
Part of Blood & lymphatic clinical trials.
This study looks at how social and financial challenges affect people getting a transplant or cell therapy at MD Anderson. Researchers want to talk to patients and their caregivers to better understand these challenges and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been cleared for a stem cell transplant or cell therapy at MD Anderson.
- You are willing to talk with a researcher about any social or financial challenges you face.
- If you are a caregiver, the patient you care for must have given permission for you to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks patients, caregivers, and cancer team members to share their experiences with “care at home” for people receiving or recently finishing cancer treatment. Your feedback will help the hospital understand what’s working and what could be improved.
This study looks at the cancer care experiences of Asian and Asian American patients who were treated at MD Anderson. By sharing your story, you can help improve care for others in your community.
This study tests a new assessment system (a set of questions/tools) to better measure how much distress cancer patients feel from symptoms. It may help cancer teams better understand your symptom burden and improve support.
This study looks at how the COVID-19 pandemic affected the experiences of teenagers and young adults with cancer, including people who finished treatment. It may help improve support for cancer patients and survivors during public health crises.
This study tests if watching short videos made by other people who faced the same decision can help you and your family feel more prepared when choosing whether to have a stem cell transplant (also called alloHCT) for your blood cancer.
This study looks at how well precision medicine (treatments based on your tumor's genes) is used for people with cancer. Researchers want to see if there are differences in who gets this kind of testing and treatment, so they can make it more fair for everyone.
Hear when a new Transplant and Cell Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.